Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?
Khairy H Morsy, Amr Zaghloul, Magdy Mahmoud
(Turk J Gastroenterol 2016; 27: 55-61) DOI: 10.5152/tjg.2015.150280


.jpg) 
         
                    .png) 
                    .png)